Magnesium Sulfate as a Second-Line Tocolytic Agent for Preterm Labor: A Randomized Controlled Trial in Kyushu Island

Table 4

Neonatal outcomes of magnesium alone and combination groups.

	MgSO4 therapy group	Combined therapy group	Comparison
Number of infants	15	23	—
Birth weight (gm) (range)	2378 ± 478 (1704–3656)	1912 ± 681 (488–2876)	NS
Gestational age (wk) (range)	35.5 ± 2.2 (32–41)	32.8 ± 4.6 (24–38)	NS
Prolongation after magnesium sulfate therapy (days)	41.5 ± 32.3 (0–108)	27.8 ± 22.3 (2–59)	NS
Apgar score at 5 min (<6)	0/15	1*/23	NS

*Neonate delivered at 24 weeks gestations (birth weight 488 gm with Apgar score 2/5 (1 min/5 min)).
NS, not significant by unpaired 𝑡-test, Mann-Whitney 𝑈 test, or Fisher test.